Weighted Average Number of Shares Outstanding, Diluted of Bone Biologics Corp from 30 Jun 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bone Biologics Corp quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2016 to 31 Dec 2025.
  • Bone Biologics Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 1,174,869, a 364% increase year-over-year.
  • Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 1,174,869, a 364% increase from 2024.
  • Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 252,960, a 3.9% decline from 2023.
  • Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 263,137, a 452% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Bone Biologics Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,174,869 +921,909 +364% 01 Oct 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 1,795,097 +1,502,776 +514% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 557,787 +362,963 +186% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 3,183,191 +2,522,263 +382% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 252,960 -10,177 -3.9% 01 Oct 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 292,321 -99,533 -25% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 194,824 -144,484 -43% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 660,928 +593,717 +883% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 263,137 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 391,854 +46,835 +14% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 339,308 -5,711 -1.7% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 67,211 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q3 2022 345,019 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 345,019 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q2 2018 4,421,247 +346,521 +8.5% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q2 2017 4,074,726 -34,077,176 -89% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q2 2016 38,151,902 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2

Bone Biologics Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 1,174,869 +921,909 +364% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 252,960 -10,177 -3.9% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 263,137 +215,479 +452% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 47,658 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.